On the recordJune 21, 2009
One of these gaps is the gap in regulation of OTC derivatives, which under current law are largely excluded or exempted from regulation.
Said by
Mary L. Schapiro
Source
congress.govOne of these gaps is the gap in regulation of OTC derivatives, which under current law are largely excluded or exempted from regulation.
Schapiro points out regulatory gaps in OTC derivatives markets.
Share
More from Mary L. Schapiro
I commend Congressman Westmoreland and Ranking Member Frank for bringing forward bipartisan legislation, H.R. 3503, to bring transparency to the PCAOB's disciplinary proceedings.
This time around, I have had more than a few people in my office weeping with fear about what might happen to them because one person or another was looking into their behavior.
Companies seeking access to capital should not be overburdened by unnecessary or superfluous regulations.